Eagle Health Investments LP

Position in RARE — Ultragenyx Pharmaceutical Inc.

CIK 1842545 Greenwich, CT

Position in RARE

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$18,522,334

-$2,443,426 QoQ

Shares Held

884,121

+26.8% QoQ

Ownership

0.898%

of shares outstanding

% of Portfolio

3.89%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2024

8 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

Eagle Health Investments LP holds $296,133,986 across 15 Biotechnology names. RARE ranks #9 (6.3% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ARGX	Argenx SE	76,336	$55,744,364
2	INSM	INSMED Inc	224,271	$36,672,793
3	BMRN	Biomarin Pharmaceutical Inc	505,809	$28,573,150
4	SRRK	Scholar Rock Holding Corp	494,019	$24,285,974
5	TERN	Terns Pharmaceuticals, Inc.	412,497	$21,746,841
6	BBIO	BridgeBio Pharma, Inc.	267,031	$19,829,722
7	ASND	Ascendis Pharma A/S	86,650	$19,819,454
8	PTGX	Protagonist Therapeutics, Inc	179,322	$18,900,538

8 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$18,522,334	884,121	+26.8%	Shares	Sole	2026-05-15
2025-09-30	$20,965,760	697,000	+11.1%	Shares	Sole	2025-11-07
2025-06-30	$22,819,536	627,600	0.0%	Shares	Sole	2025-08-12
2025-03-31	$22,725,396	627,600	0.0%	Shares	Sole	2025-05-12
2024-12-31	$26,403,132	627,600	+11.7%	Shares	Sole	2025-02-12
2024-09-30	$31,202,435	561,700	+7.1%	Shares	Sole	2024-11-12
2024-06-30	$21,556,950	524,500	+75.0%	Shares	Sole	2024-08-13
2024-03-31	$13,992,993	299,700	—	Shares	Sole	2024-05-14
No filing history on record for this holder in this stock.